Amag Leasing issued a fixed-interest, senior green bond for CHF 175 million with a coupon of 0.175 percent pa and a term of 3.75 years as part of its newly written Green Finance Framework. The Bonds have been provisionally admitted to trading on the SIX Swiss Exchange on September 13, 2021. Amag Leasing (Alag) is a subsidiary of […]
Niederer Kraft Frey has advised Swiss global private banking group Julius Baer on the bond issuance by its parent company, Julius Baer Group, of USD 320 million perpetual non-cumulative and unsecured Additional Tier 1 (AT1) securities with
Bär & Karrer advised Canada Pension Plan Investment Board (CPPIB), a professional investment management organization, as an investor in Sportradar in connection with Sportradar’s initial public offering. Sportradar is a global provider of
Banking & Finance
Capital Markets
Homburger advised Credit Suisse in the tokenization of Alaïa’s shares
Homburger acted as counsel to Credit Suisse (Switzerland) regarding the tokenization of Alaïa’s existing (registered) shares and the custody of the tokenized shares. Alaïa is one of the fastest growing action sports
Varia US Properties, a Swiss-based real estate company investing exclusively in US multifamily housing with a focus on secondary and tertiary markets, has successful issued a CHF 50 million fixed-rate bond with a coupon of 2.875% and
Holcim Sterling Finance (Netherlands) completed its issuance of GBP 250 million in aggregate principal amount of 2.250 per cent. Guaranteed notes due 2034 under its Euro Medium Term Note Programme. The notes are guaranteed by Holcim, the holding
Banking & Finance
Capital Markets
Bär & Karrer with Renaissance Capital in relation to Acronis common
Renaissance Capital, an investment firm with a focus on emerging markets, sponsored the repackaging transaction and acted as a dealer for the notes. E.M.I.S. Finance B.V., a Dutch limited recourse investment
Cosmo Pharmaceuticals and Cassiopea have entered into a transaction agreement under which Cosmo is launching a public exchange offer in Switzerland to acquire all of the publicly-held registered shares of Cassiopea. The public exchange offer
Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on the development and commercialisation of innovative medicines for rare neuromuscular neuromuscular and pulmonary diseases with high unmet medical need, has announced an equity financing of CHF 20
Pestalozzi advises global institutional investors (“Investors”) in connection with an amendment to the up to $44,000,000 equity linked investment in WISeKey International Holding (“WISeKey”) listed at SIX Swiss Exchange and with ADS traded at NASDAQ, agreed
